Đang chuẩn bị liên kết để tải về tài liệu:
Response biomarkers: Re-envisioning the approach to tailoring drug therapy for cancer

Không đóng trình duyệt đến khi xuất hiện nút TẢI XUỐNG

The rapidly expanding arsenal of chemotherapeutic agents approved in the past 5 years represents significant progress in the field. However, this poses a challenge for oncologists to choose which drug or combination of drugs is best for any individual. Because only a fraction of patients respond to any drug, efforts have been made to devise strategies to personalize care. |

TÀI LIỆU LIÊN QUAN

Expression of biomarkers in canine mammary tumours

Response biomarkers: Re-envisioning the approach to tailoring drug therapy for cancer

An inflammation-related nomogram for predicting the survival of patients with non-small cell lung cancer after pulmonary lobectomy

Intra-patient and inter-patient comparisons of DNA damage response biomarkers in Nasopharynx Cancer (NPC): Analysis of NCC0901 randomised controlled trial of induction chemotherapy in locally advanced NPC

Variations in the metabolome in response to disease activity of rheumatoid arthritis

Phase I/II study of temsirolimus for patients with unresectable Hepatocellular Carcinoma (HCC)- a correlative study to explore potential biomarkers for response

The biochemical and histoanatomical response of some woody species to anthropic impact in Suceava County, Romania

Characteristics and outcome of the COEUR Canadian validation cohort for ovarian cancer biomarkers

Case-control Indian buffet process identifies biomarkers of response to Codrituzumab

Exploratory biomarker analysis for treatment response in KRAS wild type metastatic colorectal cancer patients who received cetuximab plus irinotecan
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.